Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Explaining the genetic causality for complex diseases via deep association kernel learning

Explaining the Genetic Causality for Complex Phenotype via Deep Association Kernel Learning

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Genome-wide Causation Studies of Complex Diseases

Application Of Causal Inference To Genomic Analysis: Advances In Methodology

Implicit Causal Models for Genome-wide Association Studies

Bayesian Neural Networks for Genetic Association Studies of Complex Disease

BayesKAT: bayesian optimal kernel-based test for genetic association studies reveals joint genetic effects in complex diseases

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Mixed Linear Model Approaches of Association Mapping for Complex Traits Based on Omics Variants

Distinguishing correlation from causation using genome-wide association studies

Genetic association studies using disease liabilities from deep neural networks

A dynamic model for genome-wide association studies

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

Estimation of causal effects of genes on complex traits using a Bayesian-network-based framework applied to GWAS data

Modeling and testing for joint association using a genetic random field model

Identifying Potential Association on Gene-Disease Network Via Dual Hypergraph Regularized Least Squares

Machine Learning in Genome‐wide Association Studies

Exploring the genetic patterns of complex diseases via the integrative genome-wide approach

Pathway Analysis of Complex Diseases for GWAS, Extending to Consider Rare Variants, Multi-Omics and Interactions